CURIOSITYSTREAM INC (CURI)
US23130Q1076 - Common Stock
Taking everything into account, CURI scores 3 out of 10 in our fundamental rating. CURI was compared to 76 industry peers in the Entertainment industry. The financial health of CURI is average, but there are quite some concerns on its profitability. CURI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CURI had negative earnings in the past year.
CURI had a negative operating cash flow in the past year.
In the past 5 years CURI always reported negative net income.
CURI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
CURI has a worse Return On Assets (-48.40%) than 80.52% of its industry peers.
CURI has a Return On Equity of -67.31%. This is in the lower half of the industry: CURI underperforms 61.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.4% | ||
| ROE | -67.31% | ||
| ROIC | N/A |
ROA(3y)-32.91%
ROA(5y)-33.84%
ROE(3y)-44.62%
ROE(5y)-54.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CURI has a Gross Margin (37.51%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CURI has declined.
CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 37.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
CURI has more shares outstanding than it did 1 year ago.
CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CURI has an Altman-Z score of -2.81. This is a bad value and indicates that CURI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.81, CURI is doing worse than 79.22% of the companies in the same industry.
CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.81 |
ROIC/WACCN/A
WACC9.31%
2.3 Liquidity
CURI has a Current Ratio of 1.94. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
CURI's Current ratio of 1.94 is fine compared to the rest of the industry. CURI outperforms 70.13% of its industry peers.
A Quick Ratio of 1.94 indicates that CURI should not have too much problems paying its short term obligations.
CURI has a Quick ratio of 1.94. This is in the better half of the industry: CURI outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for CURI have decreased by -3.33% in the last year.
The Revenue for CURI has decreased by -27.10% in the past year. This is quite bad
CURI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.82% yearly.
EPS 1Y (TTM)-3.33%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q67.86%
Revenue 1Y (TTM)-27.1%
Revenue growth 3Y12.82%
Revenue growth 5YN/A
Revenue growth Q2Q1.9%
3.2 Future
Based on estimates for the next years, CURI will show a very strong growth in Earnings Per Share. The EPS will grow by 25.98% on average per year.
Based on estimates for the next years, CURI will show a small growth in Revenue. The Revenue will grow by 7.98% on average per year.
EPS Next Y80.26%
EPS Next 2Y37.49%
EPS Next 3Y27.13%
EPS Next 5Y25.98%
Revenue Next Year4.49%
Revenue Next 2Y7.49%
Revenue Next 3Y9.88%
Revenue Next 5Y7.98%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CURI. In the last year negative earnings were reported.
Also next year CURI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CURI's earnings are expected to grow with 27.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.49%
EPS Next 3Y27.13%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 9.26%, CURI is a good candidate for dividend investing.
CURI's Dividend Yield is rather good when compared to the industry average which is at 12.28. CURI pays more dividend than 97.40% of the companies in the same industry.
CURI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.26% |
5.2 History
CURI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.49%
EPS Next 3Y27.13%
CURIOSITYSTREAM INC
NASDAQ:CURI (4/26/2024, 7:00:00 PM)
After market: 1.09 -0.02 (-1.8%)1.11
+0.03 (+2.78%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap59.17M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.26% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.4% | ||
| ROE | -67.31% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 37.51% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3.33%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y80.26%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.1%
Revenue growth 3Y12.82%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y